Related Articles

Non-Communicable Diseases – Types, Risk Factors, and Prevention.

In the wake of the COVID-19 crisis, communicable diseases have become the focus of every nation yet the concern for non-communicable diseases(NCDs) cannot be overlooked. It has been noticed during the crisis that those who were suffering from comorbidities were the worst sufferers. The comorbidities were none other than non-communicable diseases(NCDs) that made people more vulnerable to the pandemic. A modeling study published in The Lancet Global Health suggests that, worldwide, one in five people are at an increased risk of severe COVID-19 if they become infected, mostly as a result of underlying NCDs. Several countries saw disruptions in providing regular healthcare services to the patients suffering from NCDs due to the focus on COVID-19 and because the economic state of the countries was in shock. The pandemic showed the extent of the burden that NCDs pose on health resources. In such a situation, the pandemic has again brought back the focus on NCDs that need to be tackled efficiently to tackle any further risk to people’s health all over the world.

Population Explosion – A Stark Reality in India

Prime Minister Narendra Modi, in his Independence Day speech, addressed the problem of population explosion in India. He termed those who opt for smaller families as patriots. He argued that the development and prosperity of the nation begin only when all the individuals are healthy and resourceful. He appealed for the public effort to reduce the population at the ground level. This speech comes with the backdrop of the UN Population Projections report that estimated that India will be the most populous country in the world through the current century.

Biotechnology Sector in India – Scope, Challenges & Government Initiatives

India’s biotechnology sector has evolved steadily and significantly in the last two decades, growing at a Compounded Annual Growth Rate (CAGR) of 20%. The government is currently aspiring to reach the target of USD 100 billion by 2025. Indeed, India has always been a high-performer when it comes to this sector. Yet, there still exist several lacunae that need to be addressed for both achieving the target and also ensuring further development…

Subscribe
Notify of
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Priyadarshi Raj
Priyadarshi Raj
8 months ago

 Parliament passed three Bills related to alternative medicine viz. The National Commission for Indian System of Medicine (NCISM) Act, 2020, The National Commission for Homoeopathy (NCH) Act, 2020 and The Institute of Teaching and Research in Ayurveda (ITRA) Act, 2020. This will further help in its integration in mainstream society by increasing scientific reliability and trust